Last reviewed · How we verify
Placebo first BA — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo first BA (Placebo first BA) — Tampere University Hospital. Placebo first BA is a bioavailability study design approach that administers placebo prior to the active drug to establish baseline pharmacokinetic parameters.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo first BA TARGET | Placebo first BA | Tampere University Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo first BA CI watch — RSS
- Placebo first BA CI watch — Atom
- Placebo first BA CI watch — JSON
- Placebo first BA alone — RSS
Cite this brief
Drug Landscape (2026). Placebo first BA — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-first-ba. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab